Avantor (NYSE:AVTR) Stock Price Up 3.9%

Avantor, Inc. (NYSE:AVTRGet Free Report) shares were up 3.9% during mid-day trading on Friday . The stock traded as high as $22.45 and last traded at $22.39. Approximately 2,932,073 shares traded hands during trading, a decline of 49% from the average daily volume of 5,711,868 shares. The stock had previously closed at $21.55.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. Robert W. Baird decreased their price target on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research note on Monday, April 29th. Evercore ISI boosted their target price on Avantor from $26.00 to $28.00 and gave the stock an “outperform” rating in a research report on Thursday, April 4th. Barclays raised their price target on Avantor from $27.00 to $30.00 and gave the company an “overweight” rating in a report on Wednesday, April 10th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on Avantor from $23.00 to $25.00 and gave the stock a “hold” rating in a research note on Thursday, April 18th. Four research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $26.71.

Read Our Latest Stock Analysis on Avantor

Avantor Trading Up 4.0 %

The company has a quick ratio of 1.05, a current ratio of 1.61 and a debt-to-equity ratio of 0.94. The company has a market capitalization of $15.22 billion, a PE ratio of 57.62, a price-to-earnings-growth ratio of 2.19 and a beta of 1.35. The stock’s 50 day moving average is $24.05 and its two-hundred day moving average is $23.75.

Avantor (NYSE:AVTRGet Free Report) last issued its quarterly earnings data on Friday, April 26th. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $0.02. The company had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.68 billion. Avantor had a net margin of 3.79% and a return on equity of 13.01%. Avantor’s revenue was down 5.6% compared to the same quarter last year. During the same period last year, the company posted $0.29 earnings per share. As a group, sell-side analysts predict that Avantor, Inc. will post 1.01 EPS for the current fiscal year.

Hedge Funds Weigh In On Avantor

A number of large investors have recently added to or reduced their stakes in AVTR. Fifth Third Bancorp grew its stake in Avantor by 125.3% during the 4th quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock worth $28,000 after buying an additional 694 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt boosted its holdings in Avantor by 565.5% in the fourth quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,331 shares of the company’s stock worth $30,000 after acquiring an additional 1,131 shares in the last quarter. Gladius Capital Management LP purchased a new stake in shares of Avantor during the fourth quarter worth about $42,000. Montag A & Associates Inc. acquired a new position in shares of Avantor during the fourth quarter valued at about $43,000. Finally, TFO Wealth Partners LLC raised its position in shares of Avantor by 203,100.0% in the 4th quarter. TFO Wealth Partners LLC now owns 2,032 shares of the company’s stock valued at $46,000 after purchasing an additional 2,031 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors.

Avantor Company Profile

(Get Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Read More

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.